Kura Oncology, Inc. (KURA)
8.26
-0.17
(-2.02%)
USD |
NASDAQ |
Mar 20, 16:00
8.26
0.00 (0.00%)
After-Hours: 20:00
Kura Oncology Research and Development Expense (Quarterly) : 64.41M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | 11.20M |
| Viemed Healthcare, Inc. | 0.598M |
| Liquidia Corp. | 16.72M |
| Agenus, Inc. | 7.511M |
| Curis, Inc. | 5.825M |